A colorectal liver metastasis prediction model based on the combination of lipoprotein-associated phospholipase A2 and serum biomarker levels
- Sisi Feng 1, Manli Zhou 1, Zixin Huang 1, Xiaomin Xiao 1, Baiyun Zhong 2
- Sisi Feng 1, Manli Zhou 1, Zixin Huang 1
- 1Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
- 2Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
- 0Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
|
January 18, 2025
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Serum lipoprotein-associated phospholipase A2 (Lp-PLA2) shows strong predictive value for colorectal liver metastasis (CRLM). A machine learning model combining Lp-PLA2 with standard markers effectively predicts CRLM, aiding early detection.
Area Of Science
- Biochemistry
- Oncology
- Medical Diagnostics
Background
- Colorectal liver metastasis (CRLM) poses a significant clinical challenge.
- Early and accurate detection of CRLM is crucial for effective patient management.
- Biomarkers for CRLM prediction require further investigation.
Purpose Of The Study
- To evaluate the predictive capability of serum lipoprotein-associated phospholipase A2 (Lp-PLA2) in patients with colorectal liver metastasis (CRLM).
- To develop and validate a machine learning (ML) model for CRLM prediction using Lp-PLA2 and conventional serological markers.
Main Methods
- Serum Lp-PLA2 levels were measured in 507 participants (162 healthy controls, 186 non-CRLM patients, 159 CRLM patients).
- A prediction model was constructed using Random Forest ML algorithm, integrating Lp-PLA2 with standard laboratory parameters (ALB, GLB, ALT, LDH, TC).
- Model performance was assessed using AUC, sensitivity, specificity, PPV, and NPV.
Main Results
- Serum Lp-PLA2 levels were significantly higher in CRLM patients compared to healthy controls and non-CRLM patients (P < 0.0001).
- The Random Forest model achieved an AUC of 0.918, demonstrating high predictive accuracy.
- The model incorporating Lp-PLA2 achieved a sensitivity of 0.823 and specificity of 0.889.
Conclusions
- Serum Lp-PLA2 is a valuable biomarker for predicting CRLM.
- The developed Random Forest model integrating Lp-PLA2 and conventional markers offers robust CRLM prediction.
- This approach shows promise for improving the early detection of colorectal liver metastasis.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

